Respiratory syncytial virus, human metapneumovirus, and parainfluenza viruses

Clinical Virology: Third Edition

Volumn , Issue , 2022, Pages 817-847

  Williams, John V ^a   Piedra, Pedro A ^b   Englund, Janet A ^c,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Human metapneumovirus (hMPV); Immune response; Parainfluenza viruses (PIVs); Respiratory diseases; Respiratory syncytial virus (RSV)

Indexed keywords

EID: 84866559692     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1128/9781555815981.ch36     Document Type: Chapter

References (260)

1. Agah, R., J. D. Cherry, A. Garakian, M. Chapin. 1987. Respiratory syncytial virus (RSV) infection rate in personnel caring for children with RSV infections. Routine isolation procedure vs routine procedure supplemented by use of masks and goggles. Am. J. Dis. Child. 141:695-697.
2. Aherne, W., T. Bird, S. Court, P. S. Gardner, J. McQuillin. 1970. Pathological changes in virus infection of the lower respiratory tract in children. J. Clin. Pathol. 23:7-18.
3. Ahluwalia, G., J. Embree, P. McNicol, B. Law, G. W. Hammond. 1987. Comparison of nasopharyngeal aspirate and nasopharyngeal swab specimens for respiratory syncytial virus diagnosis by cell culture, indirect immunofluorescence assay, enzyme-linked immunosorbent assay. J. Clin. Microbiol. 25:763-767.
4. Alvarez, R., K. S. Harrod, W. J. Shieh, S. Zaki, R. A. Tripp. 2004. Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J. Virol. 78:14003-14011.
5. Ambrose, C., P. R. Wyde, M. Ewasyshyn, A. Bonneau, B. Caplan, H. Meyer, M. Klein. 1991. Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats. Vaccine 9:505-511.
6. American Academy of Pediatrics. 1994. Parainfluenza virus infections, p. 341. In G. Peter (ed.), Red Book: Report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village, IL.
7. American Academy of Pediatrics. 2006. Diagnosis and management of bronchiolitis. Pediatrics 118:1774-1793.
8. American Academy of Pediatrics Committee on Infectious Diseases. 1998. Prevention of respiratory syncytial virus infections. Pediatrics 102:1211-1216.
9. American Academy of Pediatrics Committee on Infectious Diseases. 1996. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 97:137.
10. American Academy of Pediatrics Committee on Infectious Diseases. 1993. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics 92:501.
11. Anas, N., C. Boettrich, C. B. Hall, J. G. Brooks. 1982. The association of apnea and respiratory syncytial virus infection in infants. J. Pediatr. 101:65-68.
12. Anderson, L., C. Tsou, C. Potter, H. L. Keyserling, T. F. Smith, G. Ananaba, C. R. Bangham. 1994. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J. Infect. Dis. 170:1201-1208.
13. Apalsch, A. M., M. Green, J. Ledesma-Medina, B. Nour, E. R. Wald. 1995. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin. Infect. Dis. 20:394-399.
14. Bangham, C. R., P. J. Openshaw, L. A. Ball, A. M. King, G. W. Wertz, B. A. Askonas. 1986. Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J. Immunol. 137:3973-3977.
15. Baxter, B. D., R. B. Couch, S. B. Greenberg, J. A. Kasel. 1977. Maintenance of viability and comparison of identification methods for influenza and other respiratory viruses of humans. J. Clin. Microbiol. 6:19-22.
16. Becker, S., H. Koren, D. Henke. 1993. Interleukin- 8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1 and interleukin-6. Am. J. Respir. Cell Mol. Biol. 8:20-27.
17. Becker, S., J. Quay, J. Soukup. 1991. Cytokine (tumor necrosis factor, IL-6 and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 147:4307-4312.
18. Beeler, J. A., K. van Wyke Coelingh. 1989. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J. Virol. 63:2941-2950.
19. Beem, M., F. H. Wright, D. Hamre, M. Clements, M. Wilson, S. Hall, E. Tierny. 1960. Association of the chimpanzee coryza agent with acute respiratory disease in children. N. Engl. J. Med. 263:523.
20. Bennett, B. L., R. P. Garofalo, S. G. Cron, Y. M. Ho- sakote, R. L. Atmar, C. G. Macias, P. A. Piedra. 2007. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J. Infect. Dis. 195:1532-1540.
21. Berthaume, L., J. Poncas, V. Pavilanis. 1974. Comparative structure, morphogenesis, biological characteristics of the respiratory syncytial (RS) and pneumonia virus of mice. Arch. Gesamte Virusforsch. 45:39-51.
22. Boeckh, M., J. Englund, Y. Li, C. Miller, A. Cross, H. Fernandez, J. Kuypers, H. Kim, J. Gnann, R. Whitley. 2007. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin. Infect. Dis. 44:245-249.
23. Bont, L., C. Heijnen, A. Kavelaars, W. van Aaldern, F. Brus, J. Draaisma, S. Geelen, H. van Vught. 1999. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur. Respir. J. 14:144-149.
24. Bont, L., A. Kavelaars, C. Heijnen, H. van Vught, J. L. Kimpen. 2000. Monocyte interleukin-12 production is inversely related to duration of respiratory failure in respiratory syncytial virus bronchiolitis. J. Infect. Dis. 181:1772-1775.
25. Bosis, S., S. Esposito, H. G. Niesters, P. Crovari, A. D. Osterhaus, N. Principi. 2005. Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses. J. Med. Virol. 75:101-104.
26. Bourchier, D., K. P. Dawson, D. M. Ferguson. 1984. Humidification in viral croup: a controlled trial. Aust. Paediatr. 20:289-291.
27. Bradley, J. 1990. Environmental exposure to ribavirin aerosol. Pediatr. Infect. Dis. J. 9:595-598.
28. Cane, P. A., B. G. van den Hoogen, S. Chakrabarti, C. D. Fegan, A. D. Osterhaus. 2003. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant. 31:309-310.
29. Canonico, M., M. Kende, J. W. Huggins. 1984. Toxicology and pharmacology of ribavirin in experimental animals, p. 65. In R. Smith, V. Knight, J. Smith (ed.), Clinical Applications of Ribavirin. Academic Press, New York, NY.
30. Capasso, M., R. A. Avvisati, C. Piscopo, N. Laforgia, F. Raimondi, F. de Angelis, A. Iolascon. 2007. Cytokine gene polymorphisms in Italian preterm infants: association between interleukin-10 -1082 G/A polymorphism and respiratory distress syndrome. Pediatr. Res. 61:313-317.
31. Carmack, M., C. G. Prober. 1992. Respiratory syncytial virus and ribavirin quo vad. Infect. Agents Dis. 1: 99-107.
32. Cash, P., W. H. Wunner, C. R. Pringle. 1977. A comparison of the polypeptides of human and bovine respiratory syncytial viruses and murine pneumonia virus. Virology 82:369-379.
33. Centers for Disease Control and Prevention, Infectious Disease Society of America, American Society of Blood and Marrow Transplantation. 2000. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Morb. Mortal. Wkly. Rep. Recomm. Rep. 49:1-128, CE1-CE7.
34. Cevenini, R., M. Donati, S. Bertini, A. Moroni, V. Sambri. 1986. Capture-ELISA for sera IgM antibody to respiratory syncytial virus. J. Hyg. Camb. 97:5111.
35. Chan, P. K., R. Y. Sung, K. S. Fung, M. Hui, K. W. Chik, F. A. Adeyemi-Doro, A. F. Cheng. 1999. Epidemiology of respiratory syncytial virus infection among paediatric patients in Hong Kong: seasonality and disease impact. Epidemiol. Infect. 123:257-262.
36. Chanock, R. M. 1956. Association of a new type of cy- topathogenic myxovirus with infantile croup. J. Exp. Med. 104:555-576.
37. Chanock, R. M., H. Kim, A. Vargosko, A. Deleva, K. M. Johnson, C. Cumming, R. H. Parrott. 1961. Respiratory syncytial virus: virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, minor respiratory diseases in children. JAMA 176:647-653.
38. Chanock, R. M., R. H. Parrott, K. Cook, B. E. Andrews, J. A. Bella, T Reichelderfer, A. Z. Kapikian, F. M. Mastrota, R. J. Huebner. 1958. Newly recognized myxoviruses from children with respiratory disease. N. Engl. J. Med. 258:207-213.
39. Chanock, R. M., D. C. Wong, R. J. Huebner, J. A. Bell. 1960. Serologic response in individuals infected with parainfluenza viruses. Am. J. Public Health 50:1858-1865.
40. Cherrie, A. H., K. Anderson, G. W. Wertz, P. J. M. Openshaw. 1992. Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, 1b proteins of respiratory syncytial virus. J. Virol. 66: 2102-2110.
41. Chin, J., R. L. Magoffin, L. A. Shearer, J. H. Schieble, E. H. Lennette. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenzavirus vaccine in a pediatric population. Am. J. Epidemiol. 89:449-463.
42. Chipps, B., W. Sullivan, J. Portnoy. 1993. Alpha- 2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus. Pediatr. Infect. Dis. J. 12:653658.
43. Collins, P. L., K. McIntosh, R. M. Chanock. 1996. Respiratory syncytial virus, p. 1313. In B.N. Fields, D. M. Knipe, P. M. Howley (ed.), Fields Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, PA.
44. Cooney, M. K., J. P. Fox, C. E. Hall. 1975. The Seattle Virus Watch. VI. Observations of infections with an illness due to influenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. Am. J. Epidemiol. 101:532-551.
45. Cote, S., Y. Abed, G. Boivin. 2003. Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus. J. Clin. Microbiol. 41:36313635.
46. Couch, R. B., J. A. Englund, E. Whimbey. 1997. Respiratory viral infections in immunocompetent and immunocompromised persons. Am. J. Med. 102:2-9; discussion, 25-26.
47. Crowe, J. E., Jr. 1995. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development. Vaccine 13:415-521.
48. Cseke, G., D. W. Wright, S. J. Tollefson, J. E. Johnson, J. E. Crowe, Jr., J. V. Williams. 2007. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J. Virol. 81: 698-707.
49. Dabbous, I. A., J. S. Tkachyk, S. J. Stamm. 1966. A double blind study on the effects of corticosteroids in the treatment of bronchiolitis. Pediatrics 37:477-484.
50. de Bree, G., J. Heidema, E. van Leeuwen, G. van Bleek, R. Jonkers, H. Jansen, R. van Lier, T. Out. 2005. Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons. J. Infect. Dis. 191:17101718.
51. Denny, F. W., W. A. Clyde, Jr. 1986. Acute lower respiratory tract infections in nonhospitalized children. J. Pediatr. 108:635-646.
52. Denny, F. W., T. F. Murphy, W. A. Clyde, Jr., A. Collier, M. LaPoint, F. W. Henderson. 1983. Croup: an 11 year study in a pediatric practice. Pediatrics 71:871876.
53. De Sierra, T. M., M. L. Kumar, T. E. Wasser, B. R. Murphy, E. K. Subbarao. 1993. Respiratory syncytial virus-specific immunoglobulins in preterm infants. J. Pediatr. 122:787-791.
54. Dollner, H., K. Risnes, A. Radtke, S. A. Nordbo. 2004. An outbreak of human metapneumovirus infection in Norwegian children. Pediatr. Infect. Dis. J. 23:436-440.
55. Dominguez, E. A., L. H. Taber, R. B. Couch. 1993. Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children. J. Clin. Microbiol. 31:2286-2290.
56. Donowitz, L. G. 1987. Handwashing technique in a pediatric intensive care unit. Am. J. Dis. Child. 141:683.
57. Downham, M. A. P. S., P. S. Gardner, J. McQuillin, J. Ferris. 1975. Role of respiratory viruses in childhood mortality. Br. Med. J. 1:235-239.
58. Edwards, K. M., C. Dundon, W. A. Altemeier. 1983. Bacterial tracheitis as a complication of croup. Pediatr. Infect. Dis. J. 2:390-391.
59. Englund, J. 2005. In search of a vaccine for respiratory syncytial virus: the saga continues. J. Infect. Dis. 191: 1036-1039.
60. Englund, J., W. P. Glezen, P. A. Piedra. 1998. Maternal immunization against viral disease. Vaccine 16: 1456-1463.
61. Englund, J. A., W. P. Glezen. 1991. Maternal immunization for the prevention of infection in early infancy. Semin. Pediatr. Infect. Dis. 2:225-231.
62. Englund, J. A., M. Boeckh, J. Kuypers, W. G. Nichols, R. C. Hackman, R. A. Morrow, D. N. Fredricks, L. Corey. 2006. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann. Intern. Med. 144:344-349.
63. Englund, J. A., I. N. Mbawuike, H. Hammill, M. C. Holleman, B. D. Baxter, W. P. Glezen. 1993. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J. Infect. Dis. 168:647-656.
64. Englund, J. A., P. A. Piedra, Y. M. Ahn, B. E. Gilbert, P. Hiatt. 1994. High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J. Pediatr. 125:635-641.
65. Englund, J. A., P. A. Piedra, A. Jewell, K. Patel, B. B. Baxter, E. Whimbey. 1996. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J. Clin. Microbiol. 34:1649-1653.
66. Englund, J. A., C. J. Sullivan, M. C. Jordan, L. P. Dehner, G. M. Vercellotti, H. H. Balfour, Jr. 1988. Respiratory syncytial virus infection in immunocompromised adults. Ann. Intern. Med. 109:203-208.
67. Erdman, D. D., L. J. Anderson. 1990. Monoclonal antibody-based capture enzyme immunoassays for specific immunoglobulin G (IgG), IgA, IgM antibodies to respiratory syncytial virus. J. Clin. Microbiol. 28:27442749.
68. Ermers, M., B. Hoebee, H. Hodemaekers, T. Kimman, J. Kimpen, L. Bont. 2003. IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J. Allergy Clin. Immunol. 119:1086-1091.
69. Esper, F., R. A. Martinello, D. Boucher, C. Weibel, D. Ferguson, M. L. Landry, J. S. Kahn. 2004. A 1-year experience with human metapneumovirus in children aged <5 years. J. Infect. Dis. 189:1388-1396.
70. Falsey, A. R. 2007. Respiratory syncytial virus infection in adults. Semin. Respir. Crit. Care Med. 28:171-181.
71. Falsey, A. R., C. Cunningham, W. Barker, R. Kouides, J. Yuen, M. E. Menegus, L. Weiner. 1995. Respiratory syncytial virus and influenza infections in the hospitalized elderly. J. Infect. Dis. 172:389-394.
72. Falsey, A. R., E. E. Walsh. 1992. Humoral immunity to respiratory syncytial virus infection in the elderly. J. Med. Virol. 36:39-43.
73. Falsey, A. R., E. E. Walsh. 2000. Respiratory syncytial virus infection in adults. Clin. Microbiol. Rev. 13: 371-384.
74. Falsey, A. R., E. E. Walsh. 2006. Viral pneumonia in older adults. Clin. Infect. Dis. 42:518-524.
75. Fan, J., K. J. Henrickson, L. L. Savatski. 1998. Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, human parainfluenza virus types 1, 2, 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex). Clin. Infect. Dis. 26:1397-1402.
76. Field, C. M. B., J. H. Connolly, G. Murtagh, L. Weiner, C. Bonville, R. F. Betts. 1966. Antibiotic treatment of epidemic bronchiolitis-a double blind trial. Br. Med. J. 1:83.
77. Fishaut, M., D. Tubergen, K. McIntosh. 1980. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J. Pediatr. 96:179-186.
78. Frank, A. L., R. B. Couch, C. A. Griffis, B. D. Baxter. 1979. Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J. Clin. Microbiol. 10:32-36.
79. Frank, A. L., L. H. Taber, C. R. Wells, J. M. Wells, W. P. Glezen, A. Paredes. 1981. Patterns of shedding of myxoviruses and paramyxoviruses in children. J. Infect. Dis. 144:433.
80. Frank, J. A., Jr., R. W. Warren, J. A. Tucker, J. Zeller, C. M. Wilfert. 1983. Disseminated parainfluenza infection in a child with severe combined immunodeficiency. Am. J. Dis. Child. 137: 1172-1174.
81. Frank, A. L., W. P. Glezen. 1990. Respiratory tract infections in children in day care. Semin. Pediatr. Infect. Dis. 1:234-244.
82. Gala, C. L., C. B. Hall, K. C. Schnabel, P. H. Pincus, P. Blossom, S. W. Hildreth, R. F. Betts, R. G. Douglas, Jr. 1986. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA 256: 2706-2708.
83. Garcia, R., I. Raad, D. Abi-Said, G. Bodey, R. Cham- plin, J. Tarrand, L. A. Hill, J. Umphrey, J. Neumann, J. Englund, E. Whimbey. 1997. Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infect. Control Hosp. Epidemiol. 18:412-416.
84. Garcia-Barreno, B., C. Palomo, C. Penas, T. Delgado, P. Perez-Brena, J. A. Melero. 1989. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J. Virol. 63:925-932.
85. Garcia-Garcia, M. L., C. Calvo, I. Casas, T. Braca- monte, A. Rellan, F. Gozalo, T. Tenorio, P. Perez- Brena. 2007. Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5. Pediatr. Pulmonol. 42:458-464.
86. Gardner, P. S., S. D. Court, J. T. Brocklebank, M. A. Downham, D. Weightman. 1973. Virus crossinfection in paediatric wards. Br. Med. J. 2:571-575.
87. Garofalo, R., J. L. Kimpen, R. C. Welliver, P. L. Ogra. 1992. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr. 120:28-32.
88. Ghosh, S., R. E. Champlin, J. Englund, S. A. Giralt, K. Rolston, I. Raad, K. Jacobson, J. Neumann, C. Ippoliti, S. Mallik, E. Whimbey. 2000. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant. 25:751-755.
89. Glezen, P., F. W. Denny. 1973. Epidemiology of acute lower respiratory disease in children. N. Engl. J. Med. 288:498-505.
90. Glezen, W. P. 1984. Reactive airway disorders in children. Role of respiratory virus infections. Clin. Chest Med. 5: 635-643.
91. Glezen, W. P., A. L. Frank, L. H. Taber, J. A. Kasel. 1984. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J. Infect. Dis. 150:851-857.
92. Glezen, W. P., S. B. Greenberg, R. L. Atmar, P. A. Piedra, R. B. Couch. 2000. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283:499-505.
93. Glezen, W. P., F. A. Loda, F. W. Denny. 1997. Parainfluenza viruses, p. 551-567. In A.S. Evans and R.A. Kaslow (ed.), Viral Infections in Humans, vol. 3. Plenum Medical Books, New York, NY.
94. Glezen, W. P., A. Paredes, J. E. Allison, L. H. Taber, A. L. Frank. 1981. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, maternal antibody level. J. Pediatr. 98:708-715.
95. Glezen, W. P., L. H. Taber, A. L. Frank, J. A. Kasel. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140: 543-546.
96. Gray, G. C., A. W. Capuano, S. F. Setterquist, D. D. Erdman, N. D. Nobbs, Y. Abed, G. V. Doern, S. E. Starks, G. Boivin. 2006. Multi-year study of human metapneumovirus infection at a large US Midwestern Medical Referral Center. J. Clin. Virol. 37:269-276.
97. Groothuis, J. R., E. A. Simoes, M. J. Levin, C. B. Hall, C. E. Long, W. J. Rodriguez, J. Arrobio, H. C. Meissner, D. R. Fulton, R. C. Welliver, D. A. Tristram, G. R. Siber, G. A. Prince, M. Van Raden, V. G. Hemming for The Respiratory Syncytial Virus Immune Globulin Study Group. 1993. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N. Engl. J. Med. 329:1524-1530.
98. Gross, P. A., R. H. Green, M. G. Curnen. 1973. Persistent infection with parainfluenza type 3 virus in man. Am. Rev. Respir. Dis. 108:894-898.
99. Gruber, W. C., S. Z. Wilson, B. J. Throop, P. R. Wyde. 1987. Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat. Pediatr. Res. 21:270-274.
100. Guerrero-Plata, A., A. Casola, G. Suarez, X. Yu, L. Spetch, M. E. Peeples, R. P. Garofalo. 2006. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 34:320-329.
101. Hall, C. B. 2007. The spread of influenza and other respiratory viruses: complexities and conjectures. Clin. Infect. Dis. 45:353-359.
102. Hall, C. B., R. G. Douglas, Jr. 1975. Clinically useful method for the isolation of respiratory syncytial virus. J. Infect. Dis. 131:1-5.
103. Hall, C. B., R. G. Douglas, Jr. 1981. Modes of transmission of respiratory syncytial virus. J. Pediatr. 99: 100-103.
104. Hall, C. B., R. G. Douglas, Jr., J. M. Geiman. 1980. Possible transmission by fomites of respiratory syncytial virus. J. Infect. Dis. 141:98-102.
105. Hall, C. B., R. G. Douglas, Jr., J. M. Geiman. 1975. Quantitative shedding patterns of respiratory syncytial virus in infants. J. Infect. Dis. 132:151-156.
106. Hall, C. B., R. G. Douglas, Jr., K. C. Schnabel, J. M. Geiman. 1981. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect. Immun. 33: 779-783.
107. Hall, C. B., R. G. Douglas, Jr., R. L. Simons, J. M. Geiman. 1978. Interferon production in children with respiratory syncytial, influenza, parainfluenza virus infections. J. Pediatr. 93:28-32.
108. Hall, C. B., J. M. Geiman, B. B. Breese, R. G. Douglas, Jr. 1977. Parainfluenza viral infections in children: correlation of shedding with clinical manifestations. J. Pediatr. 91:194-198.
109. Hall, C. B., J. McBride, D. M. Galagan, S. W. Hildreth, K. C. Schnabel. 1985. Ribavirin treatment of respiratory syncytial virus infection in infants with underlying cardiopulmonary disease. JAMA 254:30473051.
110. Hall, C. B., C. A. McCarthy. 2005. Respiratory syncytial virus, p. 2008-2026. In G.L. Mandell, J. E. Bennett, R. Dolin (ed.), Principles and Practice of Infectious Diseases, 6th ed. Churchill Livingstone, Inc., New York, NY.
111. Hall, C. B., K. R. Powell, N. E. MacDonald, C. L. Gala, M. E. Menegus, S. C. Suffin, H. J. Cohen. 1986. Respiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 315:77-81.
112. Hall, C. B., K. R. Powell, K. C. Schnabel, C. L. Gala, P. H. Pincus. 1988. Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. J. Pediatr. 113:266-271.
113. Haller, A. A., T. Miller, M. Mitiku, K. Coelingh. 2000. Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. J. Virol. 74:11626-11635.
114. Hamelin, M. E., G. A. Prince, G. Boivin. 2006. Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. An- timicrob. Agents Chemother. 50:774-777.
115. Han, L. L., J. P. Alexander, L. J. Anderson. 1999. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J. Infect. Dis. 179:25-30.
116. Harrington, R. D., T. M. Hooton, R. C. Hackman, G. A. Storch, B. Osborne, C. A. Gleaves, A. Benson, J. D. Meyers. 1992. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J. Infect. Dis. 165:987-993.
117. Harrison, A. M. C., C. A. Bonville, H. F. Rosenberg, J. B. Domachowske. 1999. Respiratory syncytial virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am. J. Respir. Crit. Care Med. 159:1918-1924.
118. Harrison, R., J. Bellows, D. Rempel. 1988. Assessing exposures of health care personnel to aerosols of ribavirin. Morb. Mortal. Wkly. Rep. 37:560-563.
119. Hayden, F. G., C. A. Sable, J. D. Connor, J. Lane. 1996. Intravenous ribavirin by constant infusion for serious influenza and parainfluenzavirus infection. Antivir. Ther. 1:51-56.
120. Hemming, V. G., W. Rodriguez, H. W. Kim, C. D. Brandt, R. H. Parrott, B. Burch, G. A. Prince, P. A. Baron, R. J. Fink, G. Reaman. 1987. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob. Agents Chemother. 31:1882-1886.
121. Henderson, F. W., A. M. Collier, W. A. Clyde, Jr., F. W. Denny. 1979. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N. Engl. J. Med. 300: 530-534.
122. Henderson, F. W., A. M. Collier, M. A. Sanyal, J. M. Watkins, D. L. Fairclough, W. A. Clyde, Jr., F. W. Denny. 1982. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N. Engl. J. Med. 306:1377-1383.
123. Henrickson, K. 1995. Parainfluenza viruses, p. 14891496. In G. Mandell, R. Dolin, J. E. Bennett (ed.), Principles and Practice of Infectious Diseases, 4th ed. Churchill Livingstone, New York, NY.
124. Henrickson, K. J., L. L. Savatski. 1992. Genetic variation and evolution of human parainfluenza virus type 1 hemagglutinin neuraminidase: analysis of 12 clinical isolates. J. Infect. Dis. 166:995-1005.
125. Herfst, S., M. de Graaf, E. Scharauwen, N. Ulbrandt, A. Barnes, K. Senthil, A. Osterhaus, R. Fouchier, B. van den Hoogen. 2007. Immunization of Syrian golden hamsters with F subunit vaccine of human metapneumovirus induces protection against challenge with homologous or heterologous strains. J. Gen. Virol. 88:2702-2709.
126. Hertz, M. I., J. A. Englund, D. Snover, P. B. Bitterman, P. B. McGlave. 1989. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine (Baltimore) 68:269-281.
127. Hsu, K. H., J. E. Crowe, Jr., M. D. Lubeck, A. R. Davis, P. P. Hung, R. M. Chanock, B. R. Murphy. 1995. Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus. Vaccine 13:509-515.
128. The IMpact-RSV Study Group. 1998. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531537.
129. Isaacs, D., C. R. Bangham, A. J. McMichael. 1987. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet ii:769-771.
130. Janssen, R., L. Bont, C. L. Siezen, H. M. Hodemaek- ers, M. J. Ermers, G. Doornbos, R. van't Slot, C. Wijmenga, J. J. Goeman, J. L. Kimpen, H. C. van Hou- welingen, T. G. Kimman, B. Hoebee. 2007. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J. Infect. Dis. 196:826-834.
131. Jartti, T., B. van den Hoogen, R. P. Garofalo, A. D. Osterhaus, O. Ruuskanen. 2002. Metapneumovirus and acute wheezing in children. Lancet 360:1393-1394.
132. Jarvis, W. R., P. J. Middleton, E. W. Gelfand. 1979. Parainfluenza pneumonia in severe combined immunodeficiency disease. J. Pediatr. 94:423-425.
133. Josephs, S., H. W. Kim, C. D. Brandt, R. H. Parrott. 1988. Parainfluenza 3 virus and other common respiratory pathogens in children with human immunodeficiency virus infection. Pediatr. Infect. Dis. J. 7: 207-209.
134. Kapikian, A. Z., R. M. Chanock, T. E. Reichelderfer, T. G. Ward, R. J. Huebner, J. A. Bell. 1961. Inoculation of human volunteers with parainfluenza virus type 3. JAMA 178:537.
135. Karron, R. A., R. B. Belshe, P. F. Wright, B. Thumar, B. Burns, F. Newman, J. C. Cannon, J. Thompson, T. Tsai, M. Paschalis, S. L. Wu, Y. Mitcho, J. Hackell, B. R. Murphy, J. M. Tatem. 2003. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants. Pediatr. Infect. Dis. J. 22: 394-405.
136. Karron, R. A., K. L. O'Brien, J. L. Froehlich, V. A. Brown. 1993. Molecular epidemiology of a parainfluenza type 3 virus outbreak on a pediatric ward. J. Infect. Dis. 167:1441-1445.
137. Karron, R. A., P. F. Wright, R. B. Belshe, B. Thumar, R. Casey, F. Newman, F. P. Polack, V. B. Randolph, A. Deatly, J. Hackell, W. Gruber, B. R. Murphy, P. L. Collins. 2005. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J. Infect. Dis. 191: 1093-1104.
138. Karron, R. A., P. F. Wright, S. L. Hall, M. Makhene, J. Thompson, B. A. Burns, S. Tollefson, M. C. Steinhoff, M. H. Wilson, D. O. Harris. 1995. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, phenotypically stable in infants and children. J. Infect. Dis. 171:1107-1114.
139. Karron, R. A., P. F. Wright, F. K. Newman, M. Mak- hene, J. Thompson, R. Samorodin, M. H. Wilson, E. L. Anderson, M. L. Clements, B. R. Murphy. 1995. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J. Infect. Dis. 172:1445-1450.
140. Kasel, J. A., E. E. Walsh, A. L. Frank, B. D. Baxter, L. H. Taber, W. P. Glezen. 1987. Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children. Viral Immunol. 1:199-205.
141. Kellogg, J. A. 1991. Culture vs direct antigen assays for detection of microbial pathogens from lower respiratory tract specimens suspected of containing the respiratory syncytial virus. Arch. Pathol. Lab. Med. 115:451-458.
142. Khamapirad, T., W. P. Glezen. 1987. Clinical and radiographic assessment of acute lower respiratory tract disease in infants and children. Semin. Respir. Infect. 2: 130-144.
143. Kim, H. W., J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chanock, K. Jensen, R. H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
144. Kim, H. W., R. G. Wyatt, B. F. Fernie, C. D. Brandt, J. O. Arrobio, B. C. Jeffries, R. H. Parrott. 1983. Respiratory syncytial virus detection by immunofluorescence in nasal secretions with monoclonal antibodies against selected surface and internal proteins. J. Clin. Microbiol. 18:1399-1404.
145. Kim, Y. J., M. Boeckh, J. A. Englund. 2007. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, individuals with human immunodeficiency virus infection. Semin. Respir. Crit. Care Med. 28:222-242.
146. King, J. C., Jr., A. R. Burke, J. D. Clemens, P. Nair, J. J. Farley, P. E. Vink, S. R. Batlas, M. Rao, J. P. Johnson. 1993. Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children. Pediatr. Infect. Dis. J. 12:733-739.
147. Kisch, A. L., K. M. Johnson, R. M. Chanock. 1962. Immunofluorescence with respiratory syncytial virus. Virology 16:177-189.
148. Klassen, T. P., M. E. Feldman, L. K. Watters, T. Sutcliffe, P. C. Rowe. 1994. Nebulized budesonide for children with mild-to-moderate croup. N. Engl. J. Med. 331:285-289.
149. Kuiken, T., B. G. van den Hoogen, D. A. van Riel, J. D. Laman, G. van Amerongen, L. Sprong, R. A. Fouchier, A. D. Osterhaus. 2004. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am. J. Pathol. 164:1893-1900.
150. Kurlandsky, L. E., G. French, P. M. Webb, D. D. Porter. 1988. Fatal respiratory syncytial virus pneumonitis in a previously healthy child. Am. Rev. Respir. Dis. 138:468-472.
151. Kuypers, J., N. Wright, J. Ferrenberg, M. L. Huang, A. Cent, L. Corey, R. Morrow. 2006. Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children. J. Clin. Microbiol. 44:2382-2388.
152. Laham, F. R., V. Israele, J. M. Casellas, A. M. Garcia, C. M. Lac Prugent, S. J. Hoffman, D. Hauer, B. Thu- mar, M. I. Name, A. Pascual, N. Taratutto, M. T. Ishida, M. Balduzzi, M. Maccarone, S. Jackli, R. Pas- sarino, R. A. Gaivironsky, R. A. Karron, N. R. Polack, F. P. Polack. 2004. Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J. Infect. Dis. 189:2047-2056.
153. Lamb, R. A., D. Kolakofsky. 1996. Paramyxoviri- dae and their replication, p. 1177. In B.N. Fields, D. M. Knipe, P. M. Howley (ed.), Fields Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, PA.
154. Landau, L. I., G. C. Geelhoed. 1994. Aerosolized steroids for croup. N. Engl. J. Med. 331:322-323.
155. Larcher, C., C. Geltner, H. Fischer, D. Nachbaur, L. C. Muller, H. P. Huemer. 2005. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J. Heart Lung Transplant. 24:1891-1901.
156. Lau, S. K. P., W.-K. To, P. W. T. Tse, A. K. H. Chan, P. C. Y. Woo, H.-W. Tsoi, A. F. Y. Leung, K. S. M. Li, P. K. S. Chan, W. W. L. Lim, R. W. H. Yung, K.-H. Chan, K.-Y. Yuen. 2005. Human parainfluenza virus 4 outbreak and the role of diagnostic tests. J. Clin. Microbiol. 43:4515-4521.
157. Leclair, J. M., J. Freeman, B. F. Sullivan, C. M. Crowley, D. A. Goldmann. 1987. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N. Engl. J. Med. 317:329-334.
158. Lee, N., P. K. Chan, I. T. Yu, K. K. Tsoi, G. Lui, J. J. Sung, C. S. Cockram. 2007. Co-circulation of human metapneumovirus and SARS-associated coronavirus during a major nosocomial SARS outbreak in Hong Kong. J. Clin. Virol. 40:333-337.
159. Leer, J. A., Jr., J. L. Green, E. M. Heimlich, J. S. Hyde, H. L. Moffet, G. A. Young, B. A. Barron. 1969. Corticosteroid treatment in bronchiolitis. A controlled, collaborative study in 297 infants and children. Am. J. Dis. Child. 117:495-503.
160. Leung, J., F. Esper, C. Weibel, J. S. Kahn. 2005. Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus. J. Clin. Microbiol. 43: 1213-1219.
161. Lewis, V. A., R. Champlin, J. Englund, R. Couch, J. M. Goodrich, K. Rolston, D. Przepiorka, N. Q. Mirza, H. M. Yousuf, M. Luna, G. P. Bodey, E. Whimbey. 1996. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin. Infect. Dis. 23:1033-1037.
162. Lilic, D., A. J. Cant, M. Abinun, J. E. Calvert, G. P. Spickett. 1997. Cytokine production differs in children and adults. Pediatr. Res. 42:237-240.
163. Louie, J. K., D. P. Schnurr, C. Y. Pan, D. Kiang, C. Carter, S. Tougaw, J. Ventura, A. Norman, V. Bel- musto, J. Rosenberg, G. Trochet. 2007. A summer outbreak of human metapneumovirus infection in a long-term-care facility. J. Infect. Dis. 196:705-708.
164. Mackay, I. M., S. Bialasiewicz, Z. Waliuzzaman, G. R. Chidlow, D. C. Fegredo, S. Laingam, P. Adamson, G. B. Harnett, W. Rawlinson, M. D. Nissen, T. P. Sloots. 2004. Use of the P gene to genotype human metapneumovirus identifies 4 viral subtypes. J. Infect. Dis. 190:1913-1918.
165. Madhi, S. A., H. Ludewick, Y. Abed, K. P. Klug- man, G. Boivin. 2003. Human metapneumovirus- associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants. Clin. Infect. Dis. 37:1705-1710.
166. Madhi, S. A., H. Ludewick, L. Kuwanda, N. van Niek- erk, C. Cutland, K. P. Klugman. 2007. Seasonality, incidence, repeat human metapneumovirus lower respiratory tract infections in an area with a high prevalence of human immunodeficiency virus type-1 infection. Pediatr. Infect. Dis. J. 26:693-699.
167. Matsuda, K., H. Tsutsumi, Y. Okamoto, C. Chiba. 1995. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin. Diagn. Lab. Immunol. 2:322-324.
168. Matthey, S., D. Nicholson, S. Ruhs, B. Alden, M. Knock, K. Schultz, A. Schmuecker. 1992. Rapid detection of respiratory viruses by shell vial culture and direct staining by using pooled and individual monoclonal antibodies. J. Clin. Microbiol. 30:540-544.
169. Mbawuike, I. N., K. Fujihashi, S. DiFabio, S. Kawa- bata, J. R. McGhee, R. B. Couch, H. Kiyono. 1999. Human interleukin-12 enhances interferon- gamma-producing influenza-specific memory CD8+ cytotoxic T lymphocytes. J. Infect. Dis. 180:1477-1486.
170. McIntosh, K., R. M. Hendry, M. L. Fahnestock, L. T. Pierik. 1982. Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J. Clin. Microbiol. 16:329333.
171. McIntosh, K., H. B. Masters, I. Orr, R. K. Chao, R. M. Barkin. 1978. The immunologic response to infection with respiratory syncytial virus in infants. J. Infect. Dis. 138:24-32.
172. Meert, K. L., A. P. Sarnaik, M. J. Gelmini, M. W. Lieh-Lai. 1994. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit. Care Med. 22:566-572.
173. Meissner, H. C., S. A. Murray, M. A. Kiernan, D. R. Snydman, K. McIntosh. 1984. A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. J. Pediatr. 104:680684.
174. Meurman, O., M. Waris, K. Hedman. 1992. Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection. J. Clin. Microbiol. 30: 1479-1484.
175. Miller, W. S., M. S. Artenstein. 1967. Aerosol stability of three acute respiratory disease viruses. Proc. Soc. Exp. Biol. Med. 125:222-227.
176. Morris, J. A., R. E. Blount, Jr., R. E. Savage. 1956. Recovery of cytopathogenic agent from chimpanzees with coryza. Proc. Soc. Exp. Biol. Med. 92:544-549.
177. Muelenaer, P. M., F. W. Henderson, V. G. Hemming, E. E. Walsh, L. J. Anderson, G. A. Prince, B. R. Murphy. 1991. Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections. J. Infect. Dis. 164:15-21.
178. Mufson, M. A. 1989. Parainfluenza viruses, mumps virus, New Castle disease virus, p. 669. In E. Lennette and N.J. Schmitt (ed.), Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, 6th ed. American Public Health Association, Washington, DC.
179. Mufson, M. A., C. Orvell, B. Rafnar, E. Norrby. 1985. Two distinct subtypes of human respiratory syncytial virus. J. Gen. Virol. 66(Pt. 10):2111-2124.
180. Mulholland, K. 2007. Childhood pneumonia mortal- ity-a permanent global emergency. Lancet 370:285289.
181. Mullins, J. A., D. D. Erdman, G. A. Weinberg, K. Edwards, C. B. Hall, F. J. Walker, M. Iwane, L. J. Anderson. 2004. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg. Infect. Dis. 10:700-705.
182. Munoz, F. M., P. A. Piedra, W. P. Glezen. 2003. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine 21:3465-3467.
183. Murphy, B. R., D. W. Alling, M. H. Snyder, E. E. Walsh, G. A. Prince, R. M. Chanock, V. G. Hemming, W. J. Rodriguez, H. W. Kim, B. S. Graham. 1986. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J. Clin. Microbiol. 24:894-898.
184. Murphy, B. R., B. S. Graham, G. A. Prince, E. E. Walsh, R. M. Chanock, D. T. Karzon, P. F. Wright. 1986. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J. Clin. Microbiol. 23:1009-1014.
185. Navarro-Mari, J. M., S. Sanbonmatsu-Gamez, M. Perez-Ruiz, M. De La Rosa-Fraile. 1999. Rapid detection of respiratory viruses by shell vial assay using simultaneous culture of HEp-2, LLC-MK2, MDCK cells in a single vial. J. Clin. Microbiol. 37:2346-2347.
186. Nichols, W. G., L. Corey, T. Gooley, C. Davis, M. Boeckh. 2001. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, effect on transplant outcome. Blood 98:573-578.
187. Nichols, W. G., T. Gooley, M. Boeckh. 2001. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biol. Blood Marrow Transplant. 7(Suppl.):11S-15S.
188. Nokes, D. J., E. A. Okiro, M. Ngama, R. Ochola, L. J. White, P. D. Scott, M. English, P. A. Cane, G. F. Medley. 2008. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin. Infect. Dis. 46:5057.
189. Okamoto, Y., K. Kudo, K. Shirotori, M. Nakazawa, E. Ito, K. Togawa, J. A. Patel, P. L. Ogra. 1992. Detection of genomic sequences of respiratory syncytial virus in otitis media with effusion in children. Ann. Otol. Rhinol. Laryngol. Suppl. 157:7-10.
190. Paradiso, P. R., S. W. Hildreth, D. A. Hogerman, D. J. Speelman, E. B. Lewin, J. Oren, D. H. Smith. 1994. Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old. Pediatr. Infect. Dis. J. 13:792-798.
191. Parrott, R. H., H. Kim, C. D. Brandt. 1979. Respiratory syncytial virus, p. 695. In E. Lennette and N.J. Schmitt (ed.), Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, 5th ed. American Public Health Association, Washington, DC.
192. Paton, A. W., J. C. Paton, A. J. Lawrence, P. N. Gold- water, R. J. Harris. 1992. Rapid detection of respiratory syncytial virus in nasopharyngeal aspirates by reverse transcription and polymerase chain reaction amplification. J. Clin. Microbiol. 30:901-904.
193. Peck, A. J., L. Corey, M. Boeckh. 2004. Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation. Clin. Infect. Dis. 39: 673-680.
194. Peck, A. J., J. A. Englund, J. Kuypers, K. A. Guthrie, L. Corey, R. Morrow, R. C. Hackman, A. Cent, M. Boeckh. 2007. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 110: 1681-1688.
195. Peiris, J. S., W. H. Tang, K. H. Chan, P. L. Khong, Y. Guan, Y. L. Lau, S. S. Chiu. 2003. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg. Infect. Dis. 9:628-633.
196. Pelletier, A. J., J. M. Mansbach, C. A. Camargo, Jr. 2006. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics 118:2418-2423.
197. Piedra, P. A., S. G. Cron, A. Jewell, N. Hamblett, R. McBride, M. A. Palacio, R. Ginsberg, C. M. Oermann, P. W. Hiatt. 2003. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine 21:2448.
198. Piedra, P. A., W. P. Glezen, J. A. Kasel, R. C. Welliver, A. M. Jewel, Y. Rayford, D. A. Hogerman, S. W. Hildreth, P. R. Paradiso. 1995. Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the Western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection. Vaccine 13:1095-1101.
199. Piedra, P. A., S. Grace, A. Jewell, S. Spinelli, D. Bunting, D. A. Hogerman, F. Malinoski, P. W. Hiatt. 1996. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr. Infect. Dis. J. 15:23.
200. Piedra, P. A., A. M. Jewell, S. G. Cron, R. L. Atmar, W. P. Glezen. 2003. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine 21:3479-3482.
201. Piedra, P. A., P. R. Wyde, W. L. Castleman, M. W. Ambrose, A. M. Jewell, D. J. Speelman, S. W. Hildreth. 1993. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine 11:1415-1423.
202. Power, U. F., T. N. Nguyen, E. Rietveld, R. L. de Swart, J. Groen, A. D. Osterhaus, R. de Groot, N. Corvaia, A. Beck, N. Bouveret-Le-Cam, J. Y. Bon- nefoy. 2001. Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults. J. Infect. Dis. 184: 1456-1460.
203. Randolph, V. B., M. Kandis, P. Stemler-Higgins, M. S. Kennelly, Y. M. McMullen, D. J. Speelman, C. Weeks-Levy. 1994. Attenuated temperature-sensitive respiratory syncytial virus mutants generated by cold adaptation. Virus Res. 33:241-259.
204. Rawlinson, W. D., Z. Waliuzzaman, I. W. Carter, Y. C. Belessis, K. M. Gilbert, J. R. Morton. 2003. Asthma exacerbations in children associated with rhinovirus but not human metapneumovirus infection. J. Infect. Dis. 187:1314-1318.
205. Ray, C. G., C. J. Holberg, L. L. Minnich, Z. M. She- hab, A. L. Wright, L. M. Taussig for The Group Health Medical Associates. 1993. Acute lower respiratory illnesses during the first three years of life: potential roles for various etiologic agents. Pediatr. Infect. Dis. J. 12:10-14.
206. Ray, R., Y. Matsuoka, T. L. Burnett, B. J. Glaze, R. W. Compans. 1990. Human parainfluenza virus induces a type-specific protective immune response. J. Infect. Dis. 162:746-749.
207. Renzi, P. M., J. P. Turgeon, J. P. Yang, S. P. Drblik, J. E. Marcotte, L. Pedneault, S. Spier. 1997. Cellular immunity is activated and a TH-2 response is associated with early wheezing in infants after bronchiolitis. J. Pediatr. 130:584-593.
208. Rodriguez, W. J., R. H. Bui, J. D. Connor, H. W. Kim, C. D. Brandt, R. H. Parrott, B. Burch, J. Mace. 1987. Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimi- crob. Agents Chemother. 31:1143-1146.
209. Rosner, I. K., R. C. Welliver, P. J. Edelson, K. Geraci-Ciardullo, M. Sun. 1987. Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection. J. Infect. Dis. 155:1043-1047.
210. Saito, T., R. W. Deskin, A. Casola, H. Haeberle, B. Olszewska, P. B. Ernst, R. Alam, P. L. Ogra, R. Garofalo. 1997. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J. Infect. Dis. 175:497-504.
211. Schildgen, O., A. Simon. 2005. Induction of acute otitis media by human metapneumovirus. Pediatr. Infect. Dis. J. 24:1126.
212. Selwyn, B. J., for the Coordinated Data Group of BOSTID Researchers. 1990. The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Rev. Infect. Dis. 12(Suppl. 8):S870-S888.
213. Shay, D. K., R. C. Holman, R. D. Newman, L. L. Liu, J. W. Stout, L. J. Anderson. 1999. Bronchiolitis- associated hospitalizations among US children, 19801996. JAMA 282:1440-1446.
214. Siber, G. R., J. Leszcynski, V. Pena-Cruz, C. FerrenGardner, R. Anderson, V. G. Hemming, E. E. Walsh, J. Burns, K. McIntosh, R. Gonin. 1992. Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J. Infect. Dis. 165:456-463.
215. Simoes, E. A. 1999. Respiratory syncytial virus infection. Lancet 354:847-852.
216. Smith, D. W., L. R. Frankel, L. H. Mathers, A. T. Tang, R. L. Ariagno, C. G. Prober. 1991. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N. Engl. J. Med. 325:24-29.
217. Smyth, R. L., P. J. Openshaw. 2006. Bronchiolitis. Lancet 368:312-322.
218. Steinhorn, R. H., T. P. Green. 1990. Use of extracorporeal membrane oxygenation in the treatment of respiratory syncytial virus bronchiolitis: the national experience, 1983 to 1988. J. Pediatr. 116:338-342.
219. Storch, G. A., C. B. Hall, L. J. Anderson, C. S. Park, D. E. Dohner. 1993. Antigenic and nucleic acid analysis of nosocomial isolates of respiratory syncytial virus. J. Infect. Dis. 167:562-566.
220. Sullender, W. M., L. Sun, L. J. Anderson. 1993. Analysis of respiratory syncytial virus genetic variability with amplified cDNAs. J. Clin. Microbiol. 31: 1224-1231.
221. Sumino, K. C., E. Agapov, R. A. Pierce, E. P. Trulock, J. D. Pfeifer, J. H. Ritter, M. Gaudreault-Keener, G. A. Storch, M. J. Holtzman. 2005. Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J. Infect. Dis. 192:1052-1060.
222. Tang, R. S., K. Mahmood, M. Macphail, J. M. Guz- zetta, A. A. Haller, H. Liu, J. Kaur, H. A. Lawlor, E. A. Stillman, J. H. Schickli, R. A. Fouchier, A. D. Osterhaus, R. R. Spaete. 2005. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine 23:1657-1667.
223. Tao, T., A. P. Durbin, S. S. Whitehead, F. Davoodi, P. L. Collins, B. R. Murphy. 1998. Recovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin-neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1. J. Virol. 72:2955-2961.
224. Taussig, L. M., A. L. Wright, C. J. Holberg, M. Halonen, W. J. Morgan, F. D. Martinez. 2003. Tucson Children's Respiratory Study: 1980 to present. J. Allergy Clin. Immunol. 111:661-675; quiz, 676.
225. Tibballs, J., F. A. Shann, L. I. Landau. 1992. Placebo-controlled trial of prednisolone in children intubated for croup. Lancet 340:745-748.
226. Todd, S. J., L. Minnich, J. L. Waner. 1995. Comparison of rapid immunofluorescence procedure with TestPack RSV and Directigen FLU-A for diagnosis of respiratory syncytial virus and influenza A virus. J. Clin. Microbiol. 33:1650-1651.
227. Tristram, D. A., R. C. Welliver, C. K. Mohar, D. A. Hogerman, S. W. Hildreth, P. Paradiso. 1993. Im- munogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old. J. Infect. Dis. 167:191-195.
228. Tsutsumi, H., T. Honjo, K. Nagai, Y. Chiba, S. Chiba, S. Tsugawa. 1989. Immunoglobulin A antibody response to respiratory syncytial virus structural proteins in colostrum and milk. J. Clin. Microbiol. 27:1949-1951.
229. Vachon, M. L., N. Dionne, E. Leblanc, D. Moisan, M. G. Bergeron, G. Boivin. 2006. Human parainfluenza type 4 infections, Canada. Emerg. Infect. Dis. 12: 1755-1758.
230. Vainionpaa, R., T. Hyypia. 1994. Biology of parainfluenza viruses. Clin. Microbiol. Rev. 7:265-275.
231. van den Hoogen, B. G., J. C. de Jong, J. Groen, T. Kuiken, R. de Groot, R. A. Fouchier, A. D. Osterhaus. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7:719-724.
232. van den Hoogen, B. G., S. Herfst, L. Sprong, P. A. Cane, E. Forleo-Neto, R. L. de Swart, A. D. Osterhaus, R. A. Fouchier. 2004. Antigenic and genetic variability of human metapneumoviruses. Emerg. Infect. Dis. 10:658-666.
233. Vargas, S. O., H. P. Kozakewich, A. R. Perez-Atayde, A. J. McAdam. 2004. Pathology of human metapneumovirus infection: insights into the pathogenesis of a newly identified respiratory virus. Pediatr. Dev. Pathol. 7:478-486; discussion, 421.
234. Velayudhan, B. T., K. V. Nagaraja, A. J. Thachil, D. P. Shaw, G. C. Gray, D. A. Halvorson. 2006. Human metapneumovirus in turkey poults. Emerg. Infect. Dis. 12:1853-1859.
235. Volovitz, B., H. Faden, P. L. Ogra. 1988. Release of leukotriene C4 in respiratory tract during acute viral infection. J. Pediatr. 112:218-222.
236. Wagner, D. K., B. S. Graham, P. F. Wright, E. E. Walsh, H. W. Kim, C. B. Reimer, D. L. Nelson, R. M. Chanock, B. R. Murphy. 1986. Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. J. Clin. Microbiol. 24:304-306.
237. Wagner, D. K., D. L. Nelson, E. E. Walsh, C. B. Reimer, F. W. Henderson, B. R. Murphy. 1987. Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults. J. Clin. Microbiol. 25:748-750.
238. Wald, E. R., B. Dashefsky, M. Green. 1988. In re ribavirin: a case of premature adjudication? J. Pediatr. 112:154-158.
239. Watt, P. J., B. S. Robinson, C. R. Pringle, D. A. Tyrrell. 1990. Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines. Vaccine 8:231-236.
240. Welliver, R., D. T. Wong, T. S. Choi, P. L. Ogra. 1982. Natural history of parainfluenza virus infection in childhood. J. Pediatr. 101:180-187.
241. Welliver, R. C., D. T. Wong, E. Middleton, Jr., M. Sun, N. McCarthy, P. L. Ogra. 1982. Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J. Pediatr. 101:889896.
242. Welliver, R. C., D. T. Wong, M. Sun, E. Middleton, Jr., R. S. Vaughan, P. L. Ogra. 1981. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N. Engl. J. Med. 305:841-846.
243. Welliver, T. P., R. P. Garofalo, Y. Hosakote, K. H. Hintz, L. Avendano, K. Sanchez, L. Velozo, H. Jafri, S. Chavez-Bueno, P. L. Ogra, L. McKinney, J. L. Reed, R. C. Welliver, Sr. 2007. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195:1126-1136.
244. Wendt, C. H., D. J. Weisdorf, M. C. Jordan, H. H. Balfour, Jr., M. I. Hertz. 1992. Parainfluenza virus respiratory infection after bone marrow transplantation. N. Engl. J. Med. 326:921-926.
245. Whimbey, E., R. E. Champlin, J. A. Englund. 1995. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant. 16:393-399.
246. Whimbey, E., R. B. Couch, J. A. Englund, M. An- dreef, J. M. Goodrich, I. I. Raad, V. Lewis, N. Mirza, M. A. Luna, B. Baxter. 1995. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin. Infect. Dis. 21:376-379.
247. Whimbey, E., J. A. Englund, R. B. Couch. 1997. Community respiratory virus infections in immunocompromised patients with cancer. Am. J. Med. 102:10-18; discussion, 25-26.
248. Williams, J. V., J. E. Crowe, Jr., R. Enriquez, P. Minton, R. S. Peebles, Jr., R. G. Hamilton, S. Higgins, M. Griffin, T. V. Hartert. 2005. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J. Infect. Dis. 192:1149-1153.
249. Williams, J. V., P. A. Harris, S. J. Tollefson, L. L. Halburnt-Rush, J. M. Pingsterhaus, K. M. Edwards, P. F. Wright, J. E. Crowe, Jr. 2004. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 350:443-450.
250. Williams, J. V., R. Martino, N. Rabella, M. Otegui, R. Parody, J. M. Heck, J. E. Crowe, Jr. 2005. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J. Infect. Dis. 192:1061-1065.
251. Williams, J. V., S. J. Tollefson, P. W. Heymann, H. T. Carper, J. Patrie, J. E. Crowe. 2005. Human metapneumovirus infection in children hospitalized for wheezing. J. Allergy Clin. Immunol. 115:1311-1312.
252. Williams, J. V., S. J. Tollefson, J. E. Johnson, J. E. Crowe, Jr. 2005. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, protective immunity. J. Virol. 79:10944-10951.
253. Williams, J. V., S. J. Tollefson, S. Nair, T. Chonmaitree. 2006. Association of human metapneumovirus with acute otitis media. Int. J. Pediatr. Otorhinolaryngol. 70:1189-1193.
254. Williams, J. V., C. K. Wang, C. F. Yang, S. J. Tollefson, F. S. House, J. M. Heck, M. Chu, J. B. Brown, L. D. Lintao, J. D. Quinto, D. Chu, R. R. Spaete, K. M. Edwards, P. F. Wright, J. E. Crowe, Jr. 2006. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J. Infect. Dis. 193:387-395.
255. Wright, A. L., L. M. Taussig, C. G. Ray, H. R. Harrison, C. J. Holberg. 1989. The Tucson Children's Respiratory Study. II. Lower respiratory tract illness in the first year of life. Am. J. Epidemiol. 129:1232-1246.
256. Wright, P. F., R. A. Karron, R. B. Belshe, J. R. Shi, V. B. Randolph, P. L. Collins, A. F. O'Shea, W. C. Gruber, B. R. Murphy. 2007. The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. Vaccine 25:7372-7378.
257. Wright, P. F., R. A. Karron, R. B. Belshe, J. Thompson, J. E. Crowe, Jr., T. G. Boyce, L. L. Halburnt, G. W. Reed, S. S. Whitehead, E. L. Anderson, A. E. Wittek, R. Casey, M. Eichelberger, B. Thumar, V. B. Randolph, S. A. Udem, R. M. Chanock, B. R. Murphy. 2000. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J. Infect. Dis. 182:1331-1342.
258. Wu, H., D. S. Pfarr, S. Johnson, Y. A. Brewah, R. M. Woods, N. K. Patel, W. I. White, J. F. Young, P. A. Kiener. 2007. Development of motavizumab, an ultrapotent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J. Mol. Biol. 368:652-665.
259. Wyde, P. R., S. N. Chetty, A. M. Jewell, G. Boivin, P. A. Piedra. 2003. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antivir. Res. 60:51-59.
260. Wyde, P. R., D. K. Moore, T. Hepburn, C. L. Silverman, T. G. Porter, M. Gross, G. Taylor, S. G. Demuth, S. B. Dillon. 1995. Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats. Pediatr. Res. 38:543-550.